Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-12

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Teva Pharmaceuticals' amlodipine besylate (generic) product, signaling regulatory approval for this formulation. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)